IMMUNE MEDIATED ANEMIA

Clinical trials for IMMUNE MEDIATED ANEMIA explained in plain language.

Never miss a new study

Get alerted when new IMMUNE MEDIATED ANEMIA trials appear

Sign up with your email to follow new studies for IMMUNE MEDIATED ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Study withdrawn: extended access to fostamatinib for transplant patients never launched

Disease control Terminated

This study was designed to give people who had a stem cell transplant and developed low blood cell counts (anemia, low platelets) continued access to the drug fostamatinib. Only those who responded well in a prior study were eligible. The goal was to see if they could maintain st…

Matched conditions: IMMUNE MEDIATED ANEMIA

Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC

IMMUNE MEDIATED ANEMIA

Get alerted when new IMMUNE MEDIATED ANEMIA trials appear

Study withdrawn: extended access to fostamatinib for transplant patients never launched